UNITED STATES PHARMACOPEIAL CONVENTION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$788,657,741
Investments
52%
Property, Plant, & Equipment (net)
15%
Other Assets
9%
Inventories
8%
Cash & Equivalents
8%
Receivables (Non-Related)
6%
Prepaid Expenses
1%
Related-Party Receivables
0%
Liabilities in 2025 (Year End)
$182,029,433
Tax-Exempt Bond Liabilities
45%
Payables & Accruals
38%
Other Liabilities
12%
Deferred Revenue
5%
Grants Payable
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$59,646,065
$63,728,471
+7%
Receivables (Non-Related)
$55,757,403
$45,435,023
-19%
Related-Party Receivables
-
-
-
Inventories
$69,203,646
$65,737,416
-5%
Prepaid Expenses
$12,988,689
$10,830,119
-17%
Investments
$369,244,395
$408,498,687
+11%
Property, Plant, & Equipment (net)
$126,101,073
$119,963,693
-5%
Other Assets
$57,894,640
$74,464,332
+29%
Total Assets
$750,835,911
$788,657,741
+5%
Liabilities
2024
2025
Change
Payables & Accruals
$69,885,754
$69,379,739
-1%
Grants Payable
-
-
-
Deferred Revenue
$7,404,393
$8,208,573
+11%
Tax-Exempt Bond Liabilities
$87,329,897
$82,673,571
-5%
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$23,481,788
$21,767,550
-7%
Total Liabilities
$188,101,832
$182,029,433
-3%
Net assets
2024
2025
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$562,734,079
$606,628,308
+8%
Net assets
2024
2025
Change
Net assets
+$562,734,079
+$606,628,308
+8%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)